KL001, with the CAS number 309928-48-1, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its unique molecular structure, which contributes to its biological activity. KL001 is known to interact with specific biological targets, potentially influencing cellular processes such as proliferation and apoptosis. The compound may exhibit properties such as solubility in organic solvents and stability under various conditions, making it suitable for laboratory and pharmaceutical applications. Additionally, its safety profile and toxicity are important considerations in its development and use. As research continues, further insights into its mechanism of action, efficacy, and potential side effects will enhance our understanding of KL001's role in drug discovery and development.

KL-001 (309928-48-1) is a novel tool that specifically interacts with cryptochrome (CRY) preventing its ubiquitin-dependent degradation resulting in lengthening of the circadian period. KL-001-mediated CRY stabilization inhibits glucagon-induced gluconeogenesis in primary hepatocytes.1?Binds to the FAD-binding pocket of CRY2 as determined by co-crystal structure.2?KL-001 induces an increase in period along with simultaneous reduction in amplitude of circadian reporter expression3 in mammalian cells.

KL001

309928-48-1: KL001, with the CAS number 309928-48-1, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its unique molecular structure, which contributes to its biological activity. KL001 is known to interact with specific biological targets, potentially influencing cellular processes such as proliferation and apoptosis. The compound may exhibit properties such as solubility in organic solvents and stability under various conditions, making it suitable for laboratory and pharmaceutical applications. Additionally, its safety profile and toxicity are important considerations in its development and use. As research continues, further insights into its mechanism of action, efficacy, and potential side effects will enhance our understanding of KL001's role in drug discovery and development.

KL001 stabilizes CRY, extends circadian rhythm, inhibits gluconeogenesis, and could help develop diabetes treatments.

<p>Interacts with cytochromes in mammalian circadian clock</p>

CAS 309928-48-1

KL001

KL001

Ref: IN-DA00C29C

KL001

Ref: 54-BUP08409

KL001

Ref: TM-T22891

KL 001

Ref: 3D-FK167145